Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Production / Operations

Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY26 Q3

By The Northwire Desk — AI Analysis Feb 12, 2026 · 09:18 BU · 1.88 BURCON NUTRASCIENCE CORPORATION J
BU · Price

Executive Summary

  • Burcon Nutrascience reported Q3 2026 revenue of $739,000, a ~107% quarter‑over‑quarter increase and 1,100% year‑over‑year growth driven by the commercial launch of its Galesburg production facility.
  • The company now has 200+ active projects in its pipeline, with 65–70% of expected growth coming from existing customers who have already commercialized products.
  • Management indicated that staffing and infrastructure are fully in place, allowing incremental volume growth with limited additional fixed costs and supporting operating leverage as throughput rises.

Key Details

  • Revenue: $739,000 for Q3 2026 (≈107% QoQ increase).
  • Year‑over‑year growth: 1,100% increase versus Q3 2025.
  • Production facility: Galesburg site transitioned from development to commercial scale; launched in CY 2025 and met revenue target for the year.
  • Customer base: Approximately 65–70% of projected growth tied to repeat purchases from customers who have already commercialized their products.
  • Pipeline: Over 200 active projects under development, providing a durable source of recurring revenue.
  • Operating leverage: Management expects incremental volume growth with limited additional fixed‑cost investment, enhancing margins as throughput increases.
  • Future outlook: Double‑digit revenue growth anticipated for calendar year 2026.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from BURCON NUTRASCIENCE CORPORATION J

Jun 26, 2026 · 16:21

Stonegate updates coverage on Burcon Nutrascience Corporation (BU) 4Q26

Earnings Jun 24, 2026 · 16:12

494% revenue jump overshadowed by $14.3M loss, negative equity, and costly insider debt; liquidity a red flag.

Earnings Jun 16, 2026 · 08:01

Commercial scaling accelerates, but negative equity and explicit capital calls keep the risk/reward skewed to the downside.

Production / Operations Apr 20, 2026 · 08:01

Burcon NutraScience Ramps Production Amidst Cash Burn Concerns

Production / Operations Feb 27, 2026 · 20:10

Burcon closes $2.75M second tranche of placement

Financings Feb 27, 2026 · 16:38

Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Financings